IDEAYA Biosciences Inc.

05/23/2024 | Press release | Distributed by Public on 05/23/2024 15:06

IDEAYA Biosciences Announces Abstract Summary Results of ASCO 2024 Oral Presentation for Phase 2 Investigator Sponsored Study of Darovasertib in Neoadjuvant Uveal Melanoma

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.